WoS SCIE Q2Scopus Q1SCImago #3,229CAS 3区Hybrid

Human Gene Therapy

Abbreviation (ISO):HUM. GENE THER

Country: United States•WoS SCIE Quartile: Q2•Scopus SJR: 1.282•SCImago Rank: #3,229•Identifier (ISSN):1043-0342(Print)/1557-7422(Online)•Articles / Year: 104•Estimated Publication Fee (APC): $3,413 USD

Clarivate IF (2026)Q2

4.6

↑ +0.6

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17

H-Index (2021)

142

142 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate7.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

104articles/year

16.54% Gold OA•97.96% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

2.50pts

Latest Max Score

Estimated (Dec 26)

Scoring Basis: WoS Q1 có IF ≥ 3.0(IF: 4.6)

HĐGSNN Score History

By article publication year

Year	Max Score	Evaluation Details	Source
2026	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 4.6)	🔵 Computed
2025	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 4)	🔵 Computed
2024	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 3.9)	🔵 Computed
2023	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 4.2)	🔵 Computed
2022	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 4.793)	🔵 Computed
2021	3.00đ	WoS Q1 có IF ≥ 5.0(IF: 5.695)	🔵 Computed
2020	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 4.273)	🔵 Computed
2019	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 3.855)	🔵 Computed
2018	2.50đ	WoS Q1 có IF ≥ 3.0(IF: 4.241)	🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

Topics Covered (Recognized by AI)

Biology94.1%Genetics90.3%Medicine87.8%Chemistry87.4%Biochemistry86.8%Gene80.3%Internal medicine53.6%Genetic enhancement50.8%Immunology47.7%Recombinant DNA40.9%Virology37%Molecular biology31.3%Cell culture28.1%Cell biology26.9%Pathology26.1%Cancer research25.8%Viral vector23.9%Virus23%

Primary Research Areas

Medicine Biotechnology & Applied Microbiology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,229Scopus Q1SCImago Profile

Scopus Coverage:1990-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology

Scopus Citation Rank (SJR)Q1

1.282

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1

Scopus H-Index (2025)

167

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)

Citations / Doc (2 years)

3.78

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,413 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,237

3-Year Documents341

Citable Documents318

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GeneticsQ1

Molecular BiologyQ2

Molecular MedicineQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区BIOTECHNOLOGY & APPLIED MICROBIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed

Updating

Average time to first editorial decision

Online Publication Speed

Updating

Time from acceptance to online publication

Official Acceptance Rate

Updating

Manuscript acceptance rate confirmed by the publisher

Open Access Model

Hybrid

OA publishing option or traditional subscription

Publisher

Mary Ann Liebert Inc.

Publication Language

English

Frequency

Semimonthly

Founding Year

1990

Editorial Address

MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Indexing & Databases

SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	54/180	Q2
GENETICS & HEREDITY	JCRSCIE	38/192	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	58/191	Q2
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	50/180	Q2
GENETICS & HEREDITY	JCISCIE	57/192	Q2
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	57/191	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

Year	Impact Factor	Articles / Year	Total Citations
2026	—	95	17
2025	4	106	286
2024	3.9	84	791
2023	4.2	133	1,346
2022	4.793	125	1,644
2021	5.695	153	2,118
2020	4.273	179	3,852
2019	3.855	120	3,085
2018	4.241	159	5,969
2017	—	151	5,248
2016	—	135	4,216
2015	—	116	4,427